Planning Committee

Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner

Department of Hematology and Medical Oncology Cleveland Clinic

Cleveland, OH

Beth Sandy, MSN, CRNP

Nurse Practitioner, Thoracic Medical Oncology

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

Val R. Adams, PharmD, FCCP, FHOPA, BCOP

Associate Professor, Oncology Specialist

University of Kentucky

Lexington, KY

Faculty

Justin Baker, MD

Chief, Division of Quality of Life and Palliative Care

St. Jude Children's Research Hospital

Memphis, TN

Marianne Davies, DNP, ACNP, AOCNP, FAAN

Nurse Practitioner

Yale Comprehensive Cancer Center

New Haven, CT

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Associate Clinical Professor

University of California San Francisco

Hematology/Oncology Nurse Practitioner

San Francisco, CA

Jennie M. Goble, PA-C

Instructor in Medicine

 Mayo Clinic

 Rochester, MN

Amy Goodrich, CRNP-AC

Nurse Practitioner

Johns Hopkins Kimmel Cancer Center

Baltimore, MD

Haleigh Mistry, MS, PA-C 

Physician Assistant

The University of Texas MD Anderson Cancer Center

Houston, TX

Lauren Imboden, MMS, PA-C

Physician Assistant

Atrium Health Wake Forest Baptist

Winston Salem, NC

Ellen Marin, PA-C

Physician Assistant

Winship Cancer Institute of Emory University

Atlanta, GA

Linda M. Perry, MS, PA-C

Physician Assistant

Perelman Center for Advanced Medicine

Philadelphia, PA

Meredith Beaton, MSN, RN, AG-ACNP

Nurse Practitioner

UCHealth Anschutz

Aurora, CO

Kristi K. Orbaugh, RN, MSN, RNP, AOCN

Adult Nurse Practitioner

Community Hospital Oncology Physicians

Indianapolis, IN

Kathleen Boyle, DScPAS, PA-C 

Physician Assistant

Dana-Farber Cancer Institute

Boston, MA

Shorin Nemeth, DO

Physician

Legacy Pain Management Center at Good Samaritan

Portland, OR

Jessica Walchonski, PA-C

Physician Assistant

UCLA Health

Los Angeles, CA

Grace Baek, PharmD, BCOP

Clinical Pharmacist, Hematology/Oncology

Fred Hutchinson Cancer Center

Seattle, WA

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP

Clinical Oncology Pharmacist

University of Illinois College of Pharmacy

Chicago, IL

Jennifer Murphy, PharmD, BCOP

Senior Pharmacist

UCD Health, Oncology, and Investigational Drug Service

San Francisco, CA

Laura Wood, RN, MSN, OCN 

Nurse

Cleveland Clinic, Taussig Cancer Center

Cleveland, OH

Michael Lai, ARNP

Nurse Practitioner

Fred Hutchinson Cancer Center

Seattle, WA

Lora Johnstone, MS, NNP-BC

Nurse Practitioner

UCLA Health

Los Angeles, CA

Patricia Mangan, RN, MSN, CRNP

Nurse Lead, Hematologic Malignancies Program

Abramson Cancer Center,

University of Pennsylvania

Philadelphia, PA

Todd Hultman, PhD, ACNP, ACHPN

Palliative Care Director

Presbyterian Healthcare Services

Albuquerque, NM

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Faculty, Authors, and Content Developers Disclosures:

• Laura J. Zitella, MS, RN, ACNP-BC, AOCN discloses Speakers Bureau with Abbvie, and that relationship has ended, during the past 24 months.

• Haleigh Mistry, MS, PA-C, MS discloses Advisory Board with ADC Therapeutics and Consulting Fee with Curio Science, during the past 24 months.

• Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Boards with Janssen, Sanofi, and Karyopharm and Consulting Fees with Janssen, Sanofi, and Karyopharm , during the past 24 months.

• Lauren Imboden, PA-C discloses Speakers Bureau with Sobi, Advisory Boards with Sanofi and Genzyme, and Other with Sanofi and Genzyme, but all of these relationships have ended, during the past 24 months.

• Linda M. Perry, MS, PA-C discloses Speakers Bureau with Incyte and Sanofi, Advisory Board with Sanofi, and Consulting Fee with Sanofi and Incyte, during the past 24 months.

• Patricia Mangan, RN, MSN, CRNP discloses Speakers Bureau with BMS and Janssen, Advisory Boards with BMS and Janssen, but all of these relationships have ended, during the past 24 months.

• Kristi K. Orbaugh, RN, MSN, RNP, AOCN discloses Speakers Bureau with BMS, Pfizer, CTI, DSI, AZ, Lilly, Morphosysis, and Gilead, but all of these relationships have ended, during the past 24 months.

• Beth Sandy, MSN, CRNP discloses Advisory Boards with Lilly, Amgen, AstraZeneca, Takeda, Jazz and Merck and Consulting Fees with Janssen, during the past 24 months.

• Jessica Walchonski, PA-C discloses Advisory Board with Immunogen, but this relationship has ended, during the past 24 months.

• Jennifer Murphy, PharmD, BCOP discloses Speakers Bureau with McCreadie, but this relationship has ended, during the past 24 months.

• Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP discloses Speakers Bureau with Mirati and Advisory Board with Genetech, during the past 24 months.

• Amy Goodrich, RN, MSN, CRNP discloses Advisory Boards with BeiGene, Abbvie, AstraZeneca, Epizyme, Janssen, Sanofi, during the past 24 months.

• Laura S. Wood, RN, MSN, OCN discloses Speakers Bureau with AVEO, BMS, EMD, Serono, Exelixis, Merck and Pfizer, during the past 24 months.

Planners:

• Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Boards with Janssen, Sanofi, and Karyopharm and Consulting Fees with Janssen, Sanofi, and Karyopharm , during the past 24 months.

• Beth Sandy, MSN, CRNP discloses Advisory Boards with Lilly, Amgen, AstraZeneca, Takeda, Jazz and Merck and Consulting Fees with Janssen, during the past 24 months.           

• Val R. Adams, PharmD, FCCP, FHOPA, BCOP discloses the following relevant financial relationships: Regeneron and BMS

.